Pro Medicus Limited (PMCUF)
OTCMKTS · Delayed Price · Currency is USD
167.00
+4.00 (2.45%)
Nov 11, 2025, 9:30 AM EST
Pro Medicus Revenue
In the fiscal year ending June 30, 2025, Pro Medicus had annual revenue of 212.98M AUD with 31.88% growth. Pro Medicus had revenue of 115.79M in the half year ending June 30, 2025, with 70.25% growth.
Revenue
212.98M AUD
Revenue Growth
+31.88%
P/S Ratio
124.56
Revenue / Employee
1.61M AUD
Employees
132
Market Cap
17.39B USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 212.98M | 51.48M | 31.88% |
| Jun 30, 2024 | 161.50M | 36.60M | 29.30% |
| Jun 30, 2023 | 124.90M | 31.44M | 33.64% |
| Jun 30, 2022 | 93.46M | 25.40M | 37.31% |
| Jun 30, 2021 | 68.06M | 11.24M | 19.79% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Mid-Atlantic Home Health Network | 27.00M |
| Silence Therapeutics | 25.83M |
| Nuo Therapeutics | 2.61M |
Pro Medicus News
- 6 weeks ago - ASX 200 news from Monday 29th September 2025: Shares gain; Synlait sells North Island assets to Abbott; Novonix delivers mass-production; Pro Medicus unaffected by US tariffs. Follow live here. - The Australian Financial Review
- 6 weeks ago - Fortescue tops list of the ASX’s 10 strongest dividend stocks - The Australian Financial Review
- 2 months ago - ASX 200 Live: ASX wavers; RPMGlobal soars 25pc on Caterpillar deal, Fortescue trades ex-dividend - The Australian Financial Review
- 2 months ago - How this fundie used AI to short Guzman y Gomez – and won - The Australian Financial Review
- 3 months ago - Pro Medicus Limited 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Pro Medicus Limited (PMCUF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - What we learnt: Telstra boss Vicki Brady has achieved something that has eluded many big companies since the pandemic - The Australian Financial Review
- 3 months ago - Pro Medicus full-year profit surges 40pc on contract wins - The Australian Financial Review